ISLET Act
Islet Cell Transplantation: Regulating Cells as Organs
The ISLET Act is currently in the early stages of the legislative process. It was recently sent to the House Committee on Energy and Commerce for review. There are no upcoming votes scheduled at this time.
Part of: story →Companion bill: Organ Donation: Reclassifying Pancreas Cells for Transplants →Legislative Progress
While the bill has bipartisan support, most specialized healthcare bills struggle to get a full vote in the House without being part of a larger package.
Key Points
- This bill changes how the government classifies islet cells taken from a donor's pancreas. Currently, these cells are often treated like drugs, but this law would officially label them as human organs.
- People with Type 1 diabetes may need these cell transplants to help their bodies produce insulin again. Reclassifying them as organs is intended to make it easier and faster for hospitals to perform these life saving procedures.
- By moving these cells into the organ category, they would no longer have to follow strict rules meant for factory made medicines. Instead, they would be handled under the same systems used for heart or kidney transplants.
- The Department of Health and Human Services would have one year to update all federal regulations to match this new definition. They would also have to give a progress report to Congress within six months of the bill becoming law.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
ISLET Act
Data Sources
Sponsor
Cosponsors
(2)Analysis generated by AI. Always verify with official sources.